At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1 enrolled
Drug / intervention
Deep Brain Stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Sham-Controlled Trial Investigating Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder
In Brief
A clinical study evaluating Deep Brain Stimulation for Opioid-Related Disorders. Completed, enrolled 1 participant across 1 site.
Detailed Summary
The purpose of this clinical study is to investigate the safety, tolerability, and feasibility of Deep Brain Stimulation (DBS) of the nucleus accumbens (NAc) and ventral internal capsule (VC) for participants with treatment refractory opioid use disorder (OUD) who have cognitive, behavioral, and functional disability.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid-Related Disorders
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
N/ACompletedFinished
202420252026
First PostedJun 2023
Enrollment StartJul 2023
Primary CompletionOct 2023
Study CompletionJun 2024
TodayJul 2026
First PostedJun 15, 2023
Enrollment StartJul 1, 2023
Primary CompletionOct 17, 2023
Study CompletionJun 28, 2024
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 3.0 years ago
Interventions
Deep Brain Stimulationdevice
randomized, sham-controlled, partial crossover study investigating DBS, targeting the nucleus accumbens (NAc) and ventral internal capsule (VC), for participants with severe, treatment refractory OUD.